May 08, 2019
Prostate Cancer Foundation's Robust Collection of New Patient Resources, Including New 2019 Prostate Cancer Patient Guide Now Available
May 08, 2019
Cancer Biomarkers Market to Gain Revenue Worth US$27.63 Billion by 2025; Rise in Cancer to Boost Market Growth - TMR
May 06, 2019
HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Treatment of Prostate Cancer
Apr 29, 2019
U.S. FDA accepts New Drug Application and grants Priority Review for darolutamide
Apr 11, 2019
Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology
Apr 10, 2019
21st Century Oncology's Vladimir Ioffe, MD Urges For More Prostate Cancer Screenings Despite Government's View That 'It's Unnecessary'
Apr 02, 2019
Early Data from Phase 2 Trial Indicates Activity of Onvansertib in Prostate Cancer Patients Showing Initial Resistance to Anti-Androgen Therapy
Mar 18, 2019
MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx
Feb 27, 2019
Bayer completes rolling submission of New Drug Application to U.S. Food and Drug Administration for investigational drug darolutamide for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC)
Feb 14, 2019
Bayer's investigational drug darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
Jan 17, 2019
The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6(TM) System
Dec 21, 2018
Important Things to Know About Your Prostate Cancer Diagnosis
Nov 12, 2018
Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference
Nov 01, 2018
Combined therapy including pelvic lymph node radiation provides significant benefit for prostate cancer patients
Sep 18, 2018
Bio-Techne Announces Publication of Data Demonstrating Additional Clinical Validation of its EPI Test in European Urology Journal
Sep 18, 2018
The Prostate Cancer Foundation Reveals The First National Report About Lack Of Basic Prostate Cancer Understanding In The U.S.
Sep 11, 2018
Health-Related Quality of Life Maintained with Addition of ERLEADA® to Androgen Deprivation Therapy for Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Aug 16, 2018
The National Football League Alumni, Cancer Treatment Centers of America®, LabCorp® and Health Testing Centers Team Up to Offer Prostate Cancer Screenings in September
Jul 04, 2018
Health Canada Approves ERLEADA(TM)* (apalutamide tablets), the First Treatment for Men with Non-Metastatic Castration-Resistant Prostate Cancer
Jun 13, 2018
ITUS Corporation Announces First Commercial Focus for Cchek(TM) will be Prostate Cancer